5-year survival rates for small cell<unk>  cancer (extensive and limited) range between 3.6% and 32.2% for women, and between 2.2% and 24.5% for men. Relative 5-year survival rate for both sexes has increased from 3.6% in 1975 to 6.7% in 2014. Small-cell carcinoma is very responsive to chemotherapy and radiotherapy, and in particular, regimens based on platinum-containing agents. However, most people with the disease relapse and median survival remains low. The overall incidence and mortality rates of SCLC in the United States have decreased during the past few decades. Pie chart showing incidence of small-cell<unk>  cancer (shown in red at right), as compared to other<unk>  cancer<unk> , with fractions of smokers versus non-smokers shown for each<unk>  In limited-stage disease, relative 5-year survival rate (both sexes, all races, all ages) is 21.3%; however, women have higher 5-year survival rates, 26.9%, and men have lower survival rates, 21.3%. The prognosis is far grimmer in extensive-stage small-cell<unk>  carcinoma where 5-year relative survival rate (both sexes, all races, all ages) is 2.8%; however, women have higher 5-year survival rates, 3.4%, and men have lower 5-year survival rates, 2.2%. Long-term survival of more than 5 years can be achieved with proper treatment. According to the 17th World Conference on<unk>  Cancer (WCLC), "patients who received chest radiation and prophylactic cranial irradiation along with a mean of five chemotherapy cycles could achieve a median survival of more than 5 years." In some cases, long-term survival of 10+ years is achieved with chemotherapy and radiation alone. 5-year survival rates The SEER database tracks 5-year relative survival rates based on age, sex, and race and is considered the most accurate source of survival information. This database uses terms "Localized," "Regional," and "Distant" to describe various stages of small cell<unk>  cancer. 5-year relative survival rate for "both sexes" and "all races" affected by * "Localized" small cell<unk>  cancer is 28.5%; * "Regional" small cell<unk>  cancer 14.9%; and for * "Distant" small cell<unk>  cancer 2.9%. Survival rates by sex Women affected by small-cell<unk>  cancer have higher 5-year survival rates than men. * Localized: Women – 32.2% Men – 24.5% * Regional: Women – 17.0% Men – 12.3% * Distant: Women – 3.6% Men – 2.2% Survival rates by race, sex, age 5-year relative survival statistics are more accurate and, in some cases, higher when specific race and age range are combined with sex and stage at diagnosis. For example, * Black / Ages < = 7.0%. * White / Ages < = 6.1% National Cancer Institute's SEER maintains publicly accessible database for specific survival rates.
types of Lung cancer
medical cause of Hemoptysis
symptom of Lung cancer
medical cause of Bronchiolitis
medical cause of Bronchiectasis
types of Kidney cancer
symptom of Mesothelioma
medical cause of Neoplasm